Yatharth Hospit.

When is the next results date for Yatharth Hospit.?

No Upcoming Board Meetings

Has Yatharth Hospit. declared dividend?

No Dividend History Available

Who are the peers of the Yatharth Hospit.?

Yatharth Hospital's peers include Dr Agarwal's Healthcare, Jupiter Life Line, Health.Global, Kovai Medical, Indraprastha Medical, Artemis Medicare, Shalby, Dr Agarwal's Eye, GPT Healthcare, and Jeena Sikho. In terms of performance, Indraprastha Medical leads with a 1-year return of 99.54%, while Yatharth Hospital has a return of 38.67%.

Peers: The peers of Yatharth Hospit. are Dr Agarwal's Hea, Jupiter Life Lin, Health.Global, Kovai Medical, Indrapr.Medical, Artemis Medicare, Shalby, Dr Agarwal's Eye, GPT Healthcare, and Jeena Sikho.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jupiter Life Lin, Indrapr.Medical, and GPT Healthcare, while Good management risk is found at Dr Agarwal's Hea, Kovai Medical, and the rest. Average management risk is noted at Yatharth Hospit., Shalby, and Dr Agarwal's Eye, while Below Average management risk is seen at Health.Global and Artemis Medicare. For Growth, Excellent growth is observed at Jeena Sikho, while Good growth is found at Dr Agarwal's Hea, Yatharth Hospit., Kovai Medical, and Indrapr.Medical, and the rest. Average growth is noted at Dr Agarwal's Eye and the rest, while Below Average growth is seen at Jupiter Life Lin, Health.Global, Artemis Medicare, and Shalby. In terms of Capital Structure, Excellent capital structure is observed at Jupiter Life Lin, Indrapr.Medical, and GPT Healthcare, while Good capital structure is found at Dr Agarwal's Hea, Kovai Medical, and Shalby, and the rest. Average capital structure is noted at Artemis Medicare, while Below Average capital structure is seen at Health.Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indrapr.Medical at 99.54%, while the peer with the lowest 1-year return is Shalby at -33.71%. Yatharth Hospit.'s 1-year return is 38.67%, which is significantly lower than Indrapr.Medical's but higher than Shalby's. Additionally, the peers with negative six-month returns include Artemis Medicare and Shalby.

Who are in the management team of Yatharth Hospit.?

As of March 2022, the management team of Yatharth Hospital includes Ajay Kumar Tyagi (Chairman & Wholetime Director), Kapil Kumar (Managing Director), Yatharth Tyagi (Whole-time Director), Mukesh Sharma, Sanjeev Upadhyaya, and Promila Bhardwaj (Independent Directors), and Ritesh Mishra (Company Secretary & Compliance Officer). Each member contributes to the company's governance and operations.

As of March 2022, the management team of Yatharth Hospital includes the following members:<BR><BR>1. Ajay Kumar Tyagi - Chairman & Wholetime Director<BR>2. Kapil Kumar - Managing Director<BR>3. Yatharth Tyagi - Whole-time Director<BR>4. Mukesh Sharma - Independent Director<BR>5. Sanjeev Upadhyaya - Independent Director<BR>6. Ritesh Mishra - Company Secretary & Compliance Officer<BR>7. Promila Bhardwaj - Independent Director<BR><BR>Each member plays a crucial role in the governance and operational management of the company.

What does Yatharth Hospit. do?

Yatharth Hospital & Trauma Care Services Ltd is a mid-cap company in the hospital industry, incorporated in 2008 and converted to a public company in 2021. As of March 2025, it reported net sales of ₹2,318 Cr and a net profit of ₹387 Cr, with a market cap of ₹5,952 Cr.

Overview:<BR>Yatharth Hospital & Trauma Care Services Ltd operates in the hospital industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was incorporated as a Private Limited Company in Delhi on February 28, 2008. It converted to a Public Company on November 3, 2021, and changed its name to Yatharth Hospital & Trauma Care Services Limited on November 18, 2021. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 2,318 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 387 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 5,952 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 45.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.31 <BR>Return on Equity: 8.13% <BR>Price to Book: 3.73 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Yatharth Hospit.?

The top shareholders of Yatharth Hospital include promoter Ajay Kumar Tyagi with 30.59%, mutual funds holding 9.42%, foreign institutional investors at 4.45%, and individual investors with 14.87%. The largest public shareholder is Kotak Mahindra Trustee Co Ltd, representing the Kotak Multicap Fund, with 4.36%.

The top shareholders of Yatharth Hospital include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ajay Kumar Tyagi, with a significant stake of 30.59%. Additionally, mutual funds hold 9.42% of the shares through 8 schemes, while foreign institutional investors (FIIs) account for 4.45% with 30 different FIIs involved. The highest public shareholder is Kotak Mahindra Trustee Co Ltd, representing the Kotak Multicap Fund, which holds 4.36%. Individual investors collectively hold 14.87% of the company's shares.

How big is Yatharth Hospit.?

As of 24th July, Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of 6,119.00 Cr, with recent Net Sales of 880.49 Cr and a Net Profit of 130.54 Cr.

As of 24th July, Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of 6,119.00 Cr and is classified as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 880.49 Cr and a Net Profit of 130.54 Cr.<BR><BR>The latest annual reporting period for the balance sheet is March 2024, with Shareholder's Funds amounting to 874.32 Cr and Total Assets of 1,009.07 Cr.

Is Yatharth Hospit. overvalued or undervalued?

As of October 8, 2025, Yatharth Hospital is considered very expensive and overvalued, with a PE ratio of 56.35, an EV to EBITDA of 32.50, and a Price to Book Value of 4.99, despite having a lower PE ratio than peers like Max Healthcare and Fortis Healthcare, while significantly outperforming the Sensex with a year-to-date return of 46.93%.

As of 8 October 2025, the valuation grade for Yatharth Hospital has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 56.35, an EV to EBITDA of 32.50, and a Price to Book Value of 4.99, all of which suggest a high valuation relative to earnings and book value.<BR><BR>In comparison to its peers, Yatharth Hospital's PE ratio is lower than that of Max Healthcare at 92.31 and Fortis Healthcare at 86.26, both of which are also categorized as very expensive. However, it is notably higher than Narayana Hrudaya, which has a PE of 46.14 and is classified as expensive. The recent stock performance has outpaced the Sensex, with a year-to-date return of 46.93% compared to the Sensex's 4.65%, reinforcing the notion that the stock is currently overvalued in the market.

Is Yatharth Hospit. technically bullish or bearish?

As of November 3, 2025, Yatharth Hospital's technical trend is mildly bullish, supported by a bullish MACD and moving averages, though caution is advised due to a mildly bearish KST and lack of momentum in the RSI.

As of 3 November 2025, the technical trend for Yatharth Hospital has changed from bullish to mildly bullish. The weekly MACD remains bullish, supported by bullish signals from the Bollinger Bands on both weekly and monthly time frames. The daily moving averages also indicate a bullish stance. However, the KST on a weekly basis is mildly bearish, suggesting some caution. The RSI shows no signal on both weekly and monthly charts, indicating a lack of momentum. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and moving averages, despite some mixed signals from other indicators.

How has been the historical performance of Yatharth Hospit.?

Yatharth Hospital has shown significant growth from March 2022 to March 2025, with net sales increasing from 400.94 crore to 880.49 crore, and profit after tax rising from 44.16 crore to 130.55 crore, alongside a substantial improvement in total assets and cash flow. Overall, the hospital has demonstrated robust revenue and profitability growth during this period.

Answer:<BR>The historical performance of Yatharth Hospital shows significant growth in various financial metrics over the past few years.<BR><BR>Breakdown:<BR>Yatharth Hospital's net sales have increased from 400.94 crore in March 2022 to 880.49 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 400.94 crore in March 2022 to 880.49 crore in March 2025. The total expenditure, excluding depreciation, also grew from 290.13 crore in March 2022 to 660.30 crore in March 2025, indicating increased operational costs. Operating profit (PBDIT) has seen a notable increase, climbing from 110.81 crore in March 2022 to 236.37 crore in March 2025. Profit before tax rose from 63.11 crore in March 2022 to 171.74 crore in March 2025, while profit after tax increased from 44.16 crore to 130.55 crore in the same period. The company's total assets have surged from 420.57 crore in March 2022 to 1,713.06 crore in March 2025, with total liabilities also rising from 420.57 crore to 1,713.06 crore. Cash flow from operating activities improved significantly, moving from 59 crore in March 2022 to 149 crore in March 2025, contributing to a net cash inflow of 248 crore in March 2025, up from 6 crore in March 2022. Overall, Yatharth Hospital has demonstrated robust growth in revenue, profitability, and asset base over the past few years.

Are Yatharth Hospital & Trauma Care Services Ltd latest results good or bad?

Yatharth Hospital & Trauma Care Services Ltd's latest Q3 FY26 results show strong revenue and profit growth, with a net profit increase of 48.74% year-on-year. However, declining operating and profit margins due to rising costs raise concerns about the sustainability of this growth.

Yatharth Hospital & Trauma Care Services Ltd's latest results for Q3 FY26 present a mixed picture. On the positive side, the company reported a net profit of ₹45.35 crores, which is a significant increase of 48.74% year-on-year and a 9.97% rise compared to the previous quarter. Additionally, revenue grew impressively by 46.23% year-on-year, reaching ₹320.47 crores, and showing a sequential growth of 14.69%. This marks the seventh consecutive quarter of revenue growth, indicating strong operational traction and successful capacity expansion.<BR><BR>However, there are notable concerns regarding margin compression. The operating margin has decreased to 23.17%, down from 25.02% in Q1 FY26 and 25.06% a year ago, reflecting a decline of 185 basis points year-on-year. Similarly, the profit after tax (PAT) margin has also contracted from 16.31% in Q1 FY26 to 13.44% in Q3 FY26. This margin pressure is attributed to rising employee costs and increased depreciation charges as the company expands its facilities.<BR><BR>Overall, while the revenue and profit growth are commendable, the declining margins raise questions about the sustainability of this growth. Investors should closely monitor the company's ability to recover margins in the coming quarters, as this will be crucial for assessing its long-term performance.

Should I buy, sell or hold Yatharth Hospital & Trauma Care Services Ltd?

Which are the latest news on Yatharth Hospit.?

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 17-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price has risen to 657.40, reflecting a 1.1% increase, driven by a trend reversal and strong financial performance. Despite a recent reduction in promoter stake, the stock shows positive investor sentiment and significant returns over the past year.

As of 17-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a rise in its stock price, currently at 657.40, reflecting a change of 7.15 (1.1%) upward. This increase can be attributed to several factors. Firstly, the stock has shown a trend reversal, gaining after three consecutive days of decline, which indicates a potential recovery in investor sentiment. Additionally, the stock outperformed its sector by 0.55% today, suggesting that it is gaining traction compared to its peers.<BR><BR>Moreover, the stock reached an intraday high of Rs 669.05, which is a positive sign of investor interest. There has also been a notable increase in investor participation, with delivery volume rising by 14.98% against the five-day average, indicating growing confidence among investors. <BR><BR>Financially, the company has demonstrated strong performance, declaring positive results for the last ten consecutive quarters, with net sales reaching their highest at Rs 320.47 crore and a profit after tax (PAT) of Rs 45.35 crore. The stock has generated a remarkable return of 76.25% over the past year, significantly outperforming the market, which has only seen a return of 6.18%. <BR><BR>However, it is important to note that there are concerns regarding promoter confidence, as they have reduced their stake by 5.84% in the previous quarter. Despite this, the overall positive financial performance and recent stock movements suggest that the stock is currently on an upward trajectory.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 18-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price is rising to 672.65, reflecting a 2.34% increase. This growth is driven by strong financial performance, consecutive gains, and significant returns over the past year, despite some concerns regarding promoter confidence.

As of 18-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price is rising, currently at 672.65, reflecting a change of 15.35 (2.34%) upward. This increase can be attributed to several factors. The stock has outperformed its sector by 1.04% today and has shown consecutive gains over the last two days, with a total increase of 3.44% during this period. Additionally, the stock reached an intraday high of Rs 679.4, indicating strong investor interest.<BR><BR>The company has demonstrated robust financial performance, having declared positive results for the last ten consecutive quarters, with net sales reaching a record high of Rs 320.47 crore and a profit after tax of Rs 45.35 crore. Over the past year, the stock has generated a remarkable return of 72.03%, significantly outperforming the broader market, which returned only 5.49%. This strong performance is further supported by a low debt-to-equity ratio and a fair valuation based on its price-to-book value.<BR><BR>However, it is important to note that there are some concerns, such as a decrease in promoter confidence, with promoters reducing their stake by 5.84% in the previous quarter. Despite this, the current positive financial results and market-beating performance appear to be driving the stock's rise at this time.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 19-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price has declined to Rs 649.95, down 3.5%, due to underperformance in its sector, bearish technical indicators, and reduced promoter confidence, with promoters decreasing their stake by 5.84%.

As of 19-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a decline in its stock price, currently at Rs 649.95, which represents a decrease of Rs 23.55 or 3.5%. This downward movement can be attributed to several factors. <BR><BR>Firstly, the stock has underperformed its sector, falling by 0.68% today, and has seen a trend reversal after two consecutive days of gains. Additionally, the stock touched an intraday low of Rs 646, reflecting a decline of 4.08%. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Furthermore, the broader Hospital & Healthcare Services sector has also declined by 2.63%, contributing to the negative sentiment surrounding the stock. Despite a rise in investor participation, with a 25.55% increase in delivery volume compared to the 5-day average, the overall market conditions and sector performance appear to be weighing heavily on Yatharth Hospital's stock price.<BR><BR>Another significant factor is the reduction in promoter confidence, as promoters have decreased their stake in the company by 5.84% over the previous quarter, now holding 55.8%. This reduction may signal a lack of confidence in the company's future prospects, further influencing the stock's decline.<BR><BR>In summary, the combination of sector underperformance, bearish technical indicators, and reduced promoter confidence are key reasons for the falling stock price of Yatharth Hospital & Trauma Care Services Ltd.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 20-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price is declining at 641.30, down -1.33%. This decline is due to underperformance against its sector, consecutive drops in price, reduced investor participation, and a decrease in promoter stake, overshadowing the company's positive financial results.

As of 20-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a decline in its stock price, currently at 641.30, which reflects a change of -8.65 (-1.33%). This downward movement can be attributed to several factors. <BR><BR>Firstly, the stock has underperformed compared to its sector, with a performance today that is -1.89% lower. Additionally, it has been on a consecutive decline for the last two days, resulting in a total drop of -4.78% during this period. The stock is also trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Investor participation appears to be waning, as evidenced by a significant decrease in delivery volume, which fell by -25.75% against the 5-day average. This reduction in trading activity suggests a lack of interest or confidence among investors.<BR><BR>Moreover, there are concerns regarding promoter confidence, as the promoters have reduced their stake in the company by -5.84% over the previous quarter, now holding 55.8%. This decrease in ownership may signal a lack of confidence in the company's future prospects, further contributing to the stock's decline.<BR><BR>While the company has reported positive financial results over the last ten consecutive quarters and has shown strong returns over the past year, these factors are currently overshadowed by the negative trends in stock performance and investor sentiment.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 23-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price is declining at 621.85, down -2.99%. This drop is due to underperformance against its sector, a three-day consecutive decline, and reduced promoter confidence, despite strong financial results.

As of 23-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a decline in its stock price, currently at 621.85, which reflects a change of -19.15 (-2.99%). This downward movement can be attributed to several factors. The stock has underperformed its sector, with a performance today that is -0.59% lower than the sector average. Additionally, it has been on a consecutive decline for the last three days, resulting in a total drop of -7.67% during this period. <BR><BR>The stock opened with a loss of -2.23% today and reached an intraday low of Rs 613.1, marking a decrease of -4.35%. Furthermore, Yatharth Hospital is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The broader Hospital & Healthcare Services sector has also seen a decline of -2.37%, contributing to the negative sentiment surrounding the stock.<BR><BR>Despite the company’s strong financial performance over the past quarters, including positive results for the last ten consecutive quarters and a significant increase in net sales, the recent reduction in promoter confidence—evidenced by a -5.84% decrease in their stake—suggests concerns about the company's future prospects. This reduction in stake may signal to investors a lack of confidence from those closest to the company, further impacting the stock's performance negatively. <BR><BR>Overall, the combination of recent price declines, underperformance relative to the sector, and diminishing promoter confidence are key factors contributing to the falling stock price of Yatharth Hospital & Trauma Care Services Ltd.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 24-Mar, Yatharth Hospital & Trauma Care Services Ltd's stock price has risen to 647.85, reflecting a 4.18% increase due to a trend reversal, strong financial performance, and heightened investor interest. The stock has outperformed its sector and delivered a notable return of 48.98% over the past year.

As of 24-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a rise in its stock price, currently at 647.85, with a change of 26.0 (4.18%) upward. This increase can be attributed to several factors. Firstly, the stock has shown a trend reversal, gaining after three consecutive days of decline, which indicates a potential shift in market sentiment. Additionally, the stock outperformed its sector by 1.83%, suggesting that it is gaining traction compared to its peers.<BR><BR>The stock also reached an intraday high of Rs 652.95, reflecting positive trading activity. Notably, there has been a significant increase in investor participation, with delivery volume rising by 129.11% against the five-day average, indicating heightened interest from investors. Furthermore, the broader Hospital & Healthcare Services sector has gained by 2.35%, which may have contributed to the stock's upward movement.<BR><BR>On a fundamental level, Yatharth Hospital has demonstrated strong financial performance, declaring positive results for the last ten consecutive quarters, with net sales, PBDIT, and PAT reaching their highest levels. The company maintains a low debt-to-equity ratio, which is favorable for its financial health. Despite some concerns regarding promoter confidence due to a decrease in their stake, the stock has managed to deliver a remarkable return of 48.98% over the past year, significantly outperforming the broader market, which has seen negative returns.<BR><BR>In summary, the combination of a trend reversal, strong financial results, increased investor participation, and sector performance are key factors contributing to the rise in Yatharth Hospital & Trauma Care Services Ltd's stock price.

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 25-Mar, Yatharth Hospital & Trauma Care Services Ltd is seeing a slight rise in stock price to 648.75, but its overall performance has been mixed, with significant gains over the past year overshadowed by recent declines and reduced promoter confidence.

As of 25-Mar, Yatharth Hospital & Trauma Care Services Ltd is experiencing a slight rise in its stock price, currently at 648.75, with a change of 0.9 (0.14%). This increase follows a period of consecutive gains, as the stock has risen 4.33% over the last two days. However, it is important to note that the stock has underperformed compared to its sector, which has gained by 2.44%.<BR><BR>Despite the recent uptick, the stock has shown a decline over longer periods, with a 1-week decrease of 3.67% and a 1-month decrease of 6.94%. Year-to-date, the stock is down 4.81%, although it has performed well over the past year, generating a return of 56.33%, significantly outperforming the broader market, which has seen negative returns of -0.34%.<BR><BR>The company's financial health appears stable, with a low debt-to-equity ratio and positive results over the last ten consecutive quarters, including record net sales and profits. However, a concerning factor is the reduction in promoter confidence, as promoters have decreased their stake by 5.84% in the previous quarter, which may indicate a lack of confidence in the company's future prospects.<BR><BR>In summary, while Yatharth Hospital & Trauma Care Services Ltd is currently experiencing a slight rise in stock price, its overall performance has been mixed, with significant gains over the past year contrasted by recent declines and reduced promoter confidence.